Tetrakit Technologies is a science-driven biotech startup revolutionizing radiopharmaceutical development. Our proprietary TetraKit Platform simplifies radiolabeling for theranostic radionuclides, with a focus on alpha therapy (astatine-211), fluorine-18, iodine-131, iodine-123, and even radiometals. We develop TetraKit-based radiopharmaceuticals in-house and through global partnerships.